Percutaneous Transhepatic Intrahepatic Portosystemic Shunt for Treatment of Portal Vein Occlusion With Symptomatic Portal Hypertension After Splenectomy

Not Applicable

• Conditions: Hypertension, Portal; Portal Vein, Cavernous Transformation Of

• Registration Number: NCT02505152
• Lead Sponsor: Sun Yat-sen University

Brief Summary

To evaluate the values of percutaneous transhepatic intrahepatic portosystemic shunt for treatment of portal vein occlusion with symptomatic portal hypertension after splenectomy.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-10
• Study First Submitted: 2015-07-16
• Study First Submitted QC: 2015-07-20
• Study First Posted: 2015-07-22
• Status Verified: 2015-11
• Last Update Submitted: 2015-11-10
• Last Update Posted: 2015-11-11
• Primary Completion: 2016-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• All patients with portal hypertension who have the history of splenectomy and have enough image information to confirm occlusion of portal vein

Exclusion Criteria

• Patients with known severe dysfunction of heart, lung, brain, kidney and other vital organs

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
No gastrointestinal rebleeding in 1 month after interventions	1 month	No gastrointestinal rebleeding in 1 month after interventions
Ascites disappear in 1 month after interventions	1 month	Ascites disappear in 1 month after interventions

Secondary Outcome Measures

Name	Time	Method
Whether the shunt is patent after interventions in 6 months	6 months	Patent shunt in 6 months after interventions proved by US or CT

Trial Locations

Locations (1)

Department of Radiology; 🇨🇳 Guangzhou, Guangdong, China